Detail akcie Outset Medical Rg online

Business Summary: Outset Medical, Inc. is a medical technology company. It offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. It designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. Tablo Console is a proprietary, compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Outset Medical Inc revenues increased 5% to $119.5M. Net loss decreased 36% to $81.7M. Revenues reflect Product revenue increase of 5% to $84.8M, Service and other revenue increase of 6% to $34.7M. Lower net loss reflects Research and development decrease of 38% to $17.8M (expense), Sales and marketing - Balancing value decrease of 17% to $51.3M (expense).